Johnson & Johnson (JNJ)
(Delayed Data from NYSE)
$167.33 USD
+2.59 (1.57%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $167.32 -0.01 (-0.01%) 7:58 PM ET
2-Buy of 5 2
B Value F Growth C Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
For Johnson & Johnson, the company has a dividend yield of 3.16% compared to the Large Cap Pharmaceuticals industry's yield of 3.16%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
JNJ 167.33 +2.59(1.57%)
Will JNJ be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for JNJ based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for JNJ
3 Medical Stocks to Consider as Markets Take a Breather
JNJ or AZN: Which Pharma Giant is a Better Buy Post Q2 Results?
JNJ: What are Zacks experts saying now?
Zacks Private Portfolio Services
Buy 5 Wide Moat Stocks to Enhance Your Portfolio Returns
TEVA Q2 Earnings Beat, Revenues Miss on Lower Generics Sales
AbbVie Beats on Q2 Earnings & Sales, Stock Up on Raised '25 EPS View
Other News for JNJ
5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8.5% (August 2025)
ClearBridge Value Portfolios Q2 2025 Commentary
Market Voices: Trump vs. Big Pharma, Swiss tariffs, tariff legality
Trump Trade: Trump signs executive order raising tariff on Canada to 35%
European pharmaceutical stocks slip after Trump pushes for lower drug prices